» Articles » PMID: 35320935

T Cells and Cytokines in Encephalitogenic Disorders

Overview
Journal Front Immunol
Date 2022 Mar 24
PMID 35320935
Authors
Affiliations
Soon will be listed here.
Abstract

The invasion of immune cells into the central nervous system (CNS) is a hallmark of the process we call neuroinflammation. Diseases such as encephalitides or multiple sclerosis (MS) are characterised by the dramatic influx of T lymphocytes and monocytes. The communication between inflammatory infiltrates and CNS resident cells is primarily mediated through cytokines. Over the years, numerous cytokine networks have been assessed to better understand the development of immunopathology in neuroinflammation. In MS for instance, many studies have shown that CD4 T cells infiltrate the CNS and subsequently lead to immunopathology. Inflammatory CD4 T cells, such as T1, T17, GM-CSF-producing helper T cells are big players in chronic neuroinflammation. Conversely, encephalitogenic or meningeal regulatory T cells (T) and T2 cells have been shown to drive a decrease in inflammatory functions in microglial cells and thus promote a neuroprotective microenvironment. Recent studies report overlapping as well as differential roles of these cells in tissue inflammation. Taken together, this suggests a more complex relationship between effector T cell subsets in neuroinflammation than has hitherto been established. In this overview, we review the interplay between helper T cell subsets infiltrating the CNS and how they actively contribute to neuroinflammation and degeneration. Importantly, in this context, we will especially focus on the current knowledge regarding the contribution of various helper cell subsets to neuroinflammation by referring to their helper T cell profile in the context of their target cell.

Citing Articles

Targeting Cytokine-Mediated Inflammation in Brain Disorders: Developing New Treatment Strategies.

Mallick R, Basak S, Chowdhury P, Bhowmik P, Das R, Banerjee A Pharmaceuticals (Basel). 2025; 18(1).

PMID: 39861166 PMC: 11769149. DOI: 10.3390/ph18010104.


The impact of cryopreservation on cytokine secretion and polyfunctionality in human PBMCs: a comparative study.

Linder A, Portmann K, Eyer K Front Immunol. 2024; 15:1478311.

PMID: 39434875 PMC: 11491348. DOI: 10.3389/fimmu.2024.1478311.


Life history of a brain autoreactive T cell: From thymus through intestine to blood-brain barrier and brain lesion.

Kawakami N, Wekerle H Neurotherapeutics. 2024; 21(6):e00442.

PMID: 39237437 PMC: 11585894. DOI: 10.1016/j.neurot.2024.e00442.


Obesity intensifies sex-specific interferon signaling to selectively worsen central nervous system autoimmunity in females.

Cordeiro B, Ahn J, Gawde S, Ucciferri C, Alvarez-Sanchez N, Revelo X Cell Metab. 2024; 36(10):2298-2314.e11.

PMID: 39168127 PMC: 11463735. DOI: 10.1016/j.cmet.2024.07.017.


Oligodendrocyte precursor cell-derived exosomes combined with cell therapy promote clinical recovery by immunomodulation and gliosis attenuation.

Santos S, Ortiz-Penuela S, de Paula Filho A, Tomiyama A, Coser L, da Silveira J Front Cell Neurosci. 2024; 18:1413843.

PMID: 39109218 PMC: 11301646. DOI: 10.3389/fncel.2024.1413843.


References
1.
Conti H, Shen F, Nayyar N, Stocum E, Sun J, Lindemann M . Th17 cells and IL-17 receptor signaling are essential for mucosal host defense against oral candidiasis. J Exp Med. 2009; 206(2):299-311. PMC: 2646568. DOI: 10.1084/jem.20081463. View

2.
Matusevicius D, Kivisakk P, He B, Kostulas N, Ozenci V, Fredrikson S . Interleukin-17 mRNA expression in blood and CSF mononuclear cells is augmented in multiple sclerosis. Mult Scler. 1999; 5(2):101-4. DOI: 10.1177/135245859900500206. View

3.
Capone A, Bianco M, Ruocco G, De Bardi M, Battistini L, Ruggieri S . Distinct Expression of Inflammatory Features in T Helper 17 Cells from Multiple Sclerosis Patients. Cells. 2019; 8(6). PMC: 6628300. DOI: 10.3390/cells8060533. View

4.
Kebir H, Kreymborg K, Ifergan I, Dodelet-Devillers A, Cayrol R, Bernard M . Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation. Nat Med. 2007; 13(10):1173-5. PMC: 5114125. DOI: 10.1038/nm1651. View

5.
Sonnenberg G, Nair M, Kirn T, Zaph C, Fouser L, Artis D . Pathological versus protective functions of IL-22 in airway inflammation are regulated by IL-17A. J Exp Med. 2010; 207(6):1293-305. PMC: 2882840. DOI: 10.1084/jem.20092054. View